cancer
Merck in Advanced Talks to Buy Seagen in Nearly US$ 40 Billion Deal

Merck in Advanced Talks to Buy Seagen in Nearly US$ 40 Billion Deal

Merck & Co is in advanced talks to buy cancer-focused biotech company Seagen Inc in a deal that could be worth roughly US$ 40 billion.

Merck in Advanced Talks to Buy Seagen in Nearly US$ 40 Billion Deal
IHSG
7.172,43
0.20%
-14,12
LQ45
1.022,99
0.33%
-3,35
USD/IDR
14.822
0,37
EMAS
974.000
0,10%